Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension.
Jing WuShitong XieXiaoning HeGang ChenGengliang BaiDa FengMing HuJie JiangXiaohui WangHongyan WuQunhong WuJohn E BrazierPublished in: PharmacoEconomics (2021)
The Chinese value set for the SF-6Dv2 was established based on the TTO approach, but the DCETTO also performed well. Minor issues of non-monotonicity did present for DCETTO.